NanoString Technologies Inc (NSTG) has gained 2.49% Thursday In Premarket Trading – InvestorsObserver
NanoString Technologies Inc (NSTG) has risen Thursday morning, with the stock adding 2.49% in pre-market trading to 7.83. NSTG’s short-term technical score of 6 indicates that the stock has traded less bullishly over the last month than 94% of stocks on the market. In the Medical Instruments & Supplies industry, which ranks 122 out of 146 industries, NanoString Technologies Inc ranks higher than 10% of stocks. NanoString Technologies Inc has fallen 0.39% over the past month, closing at $6.64 on November 17. During this period of time, the stock fell as low as $5.87 and as high as $8.22. NSTG has an average analyst recommendation of Strong Buy. The company has an average price target of $17.00.
NanoString Technologies Inc has a Long-Term Technical rank of 7. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 93% of the market scoring higher. In the Medical Instruments & Supplies industry which is number 104 by this metric, NSTG ranks better than 104% of stocks.
Important Dates for Investors in NSTG:
-NanoString Technologies Inc is set to release earnings on 2/5/2023. Over the last 12 months, the company has reported EPS of $-3.14. -We do not have a set dividend date for NanoString Technologies Inc at this time. Click Here To Get The Full Report on NanoString Technologies Inc (NSTG)
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You’re all set to receive the Morning Update newsletter
Stock Price data may be delayed up to 15 minutes.
Copyright © 2022. Portions of this content may be copyrighted by Fresh Brewed Media, Investors Observer, and/or O2 Media LLC. All Rights Reserved. Portions of this content protected by US Patent numbers 7,865,496, 7,856,390, and 7,716,116. Investing in stocks, bonds, option and other financial instruments involve risks and may not be suitable for everyone. Portfolio results are unaudited and based on varying investment expiration dates. Terms of Service | Privacy Policy